Prostate Cancer Solution Guidebooks to be Donated to Patient Support Groups

Sarasota, FL (PRWEB) April 23, 2009 -- The Dattoli Cancer Foundation has announced a complimentary "book giveaway" for prostate cancer support groups nationwide. The new patient guidebook, The Dattoli Blue Ribbon Prostate Cancer Solution, was published last month, coauthored by Michael J. Dattoli, M.D, the founder and Physician-in-Chief of the Dattoli Cancer Center & Brachytherapy Research Institute, and Jennifer Cash, ARNP, OCN. One book will be shipped without charge to each of the first 250 legitimate support organizations and libraries who contact the foundation. Local and national group leaders of Man to Man, Us Too, International, and PAACT are invited to request copies of the book by contacting Ginya Carnahan at the Dattoli Cancer Foundation.

The Dattoli Blue Ribbon Prostate Cancer Solution provides a thorough, step by step examination of diagnosis and treatment of this disease. According to the American Cancer Society, more than 180,000 men were diagnosed with prostate cancer in the U.S. last year, the second most common cancer found in men. Citing the most recent studies, including Dr. Dattoli's own 16-year data, the authors report that radical surgery has now been surpassed by a new 'gold standard' prostate cancer treatment protocol that combines radioactive seed implants (brachytherapy) with the most sophisticated external radiation, known as 4-Dimensional Image-Guided Intensity Modulated Radiation Therapy (4D IG-IMRT) with DART™ (Dynamic Adaptive Radiotherapy).

Dr. Dattoli, a pioneer of brachytherapy and IMRT research, has published numerous peer-reviewed studies and now has the most successful long-term prostate cancer cure rates in the world. His most recent prostate cancer solutions study was presented in February at a genitourinary cancers symposium for the American Society of Clinical Oncology (ASCO). Dr. Dattoli explained the importance of his prostate cancer cure rate findings, "The now greater than 16-year disease-free survival rate for patients who have completed our combined brachytherapy protocol is superior to any results reported with surgery (traditional radical or robotic) or with any other current prostate cancer treatment options -- and with far less risk of complications such as erectile dysfunction and incontinence. In recent decades, we have seen a revolution in the field. Advances in the delivery of high energy photons, color Doppler ultrasound imaging, and computerized prostate cancer treatment planning have essentially turned the tide against what was previously thought to be a disease most effectively treated by means of radical surgery. We are now routinely curing prostate cancer patients who were once thought to be incurable."

In The Dattoli Blue Ribbon Prostate Cancer Solution, the authors discuss the pros and cons of all currently available prostate cancer treatment options. In the past, most men diagnosed with prostate cancer were typically referred by their family doctors to urologists, who routinely advised them to undergo surgery. With a bias favoring their own prostate cancer solution specialty, many urologists ignore the data and continue to recommend surgery to their patients. According to Dr. Dattoli, "Many surgeons don't inform their patients that even in the best surgical hands or utilizing the newest prostate cancer robotic treatments, there is a great likelihood that a man will be wearing diapers the rest of his life, and he is also very likely to suffer from erectile dysfunction, even with nerve-sparing surgery, Viagra and similar remedies.

"We now know that in addition to those unwanted prostate cancer treatment side effects, surgical removal of the prostate leaves behind cancer in as many as half of those patients who are characterized as intermediate or high risk. By contrast, in our program even higher risk patients (those with high PSA values, high Gleason scores and locally advanced cancer) have enjoyed an 82% success rate out to 16 years, while low risk patients have a success rate greater than 90%. The disadvantages of radical prostate cancer treatment surgery compared to state-of-the-art radiation therapy have caused many patients to reconsider their prostate cancer solution options.

"To a large extent, the increasing popularity of brachytherapy and IMRT has been patient-driven. Men are doing their homework on prostate cancer solutions and treatments by reading the medical literature, joining support groups and searching on the internet. They are finding that the data increasingly favors non-invasive treatments like Palladium-103 brachytherapy and 4D IG-IMRT. At this time, an overview of prostate cancer solutions and treatment from a non-surgical perspective, as presented in our book, is crucial for every patient wishing to receive the highest standard of care."

The Dattoli Blue Ribbon Prostate Cancer Solution: How to Survive and Thrive without Surgery also is available for $19.95 on Amazon.com, or by calling the Dattoli Cancer Foundation at (800) 915-1001, or by visiting our Websites:

http://www.pca-survivingwithoutsurgery.com

http://www.dattolifoundation.org/

The Dattoli Blue Ribbon Prostate Cancer Solution: How to Survive and Thrive Without Surgery: Paperback. 280 pages. 24 color illustrations, medical glossary, resource directory. ISBN-10: 0979468094 -- Pub date: March 29, 2009.

About Dattoli Cancer Center & Foundation:

The Dattoli Cancer Center was created by a core group of experts in the field of prostate cancer treatment; each highly respected in the revolutionary field of brachytherapy and Intensity Modulated Radiation Therapy (IMRT) for the treatment of prostate cancer. The Dattoli Team has been refining brachytherapy prostate cancer treatment techniques since 1986 and has built the largest brachytherapy and 4D IG-IMRT program in the country.

Contact:

Ginya Carnahan, APR, CPRC

Director of Marketing & Development

Dattoli Cancer Center & Foundation

2803 Fruitville Road - Sarasota, FL 34237

800-915-1001

http://www.dattoli.com

# # #